This wiki has undergone a migration to Confluence found Here
Difference between revisions of "20160524 US Realm SC Call"
Jump to navigation
Jump to search
(→Agenda) |
|||
Line 15: | Line 15: | ||
'''Location: '''call 770-657-9270 using code 156896#<br/> [https://global.gotomeeting.com/join/929752237 929-752-237] | '''Location: '''call 770-657-9270 using code 156896#<br/> [https://global.gotomeeting.com/join/929752237 929-752-237] | ||
− | | colspan="2" align="left" style="background:#f0f0f0;"|'''Date: 2016- | + | | colspan="2" align="left" style="background:#f0f0f0;"|'''Date: 2016-05-24'''<br/> '''Time: 1 PM Eastern''' |
|- | |- | ||
| colspan="1" align="right"|'''Co-Chairs''' | | colspan="1" align="right"|'''Co-Chairs''' |
Revision as of 20:51, 23 May 2016
back to US_Realm_Steering_Committee
back to US_Realm_Steering_Committee_Conference_Calls
US Realm Steering Committee Call Agenda/Minutes Location: call 770-657-9270 using code 156896# |
Date: 2016-05-24 Time: 1 PM Eastern | ||
Co-Chairs | Ed/Brett | Note taker(s) | Anne |
Attendee / Name | |||||||||||
Calvin Beebe | Keith Boone | Hans Buitendijk | |||||||||
Lorraine Constable | Johnathan Coleman | Ed Hammond | |||||||||
Tony Julian | Paul Knapp | Austin Kreisler | |||||||||
Brett Marquard | Ken McCaslin | Nancy Orvis | |||||||||
Brian Pech | Wayne Kubick | Mark Roche | |||||||||
Sandra Stuart | . | Pat Van Dyke | . | Anne Wizauer | |||||||
Danielle Friend | . | Eric Haas | . | Jenni Syed | |||||||
Steve Posnak | . | David Susanto | . | Visitor / Name | |||||||
no quorum definition |
Agenda
Administrivia
- Agenda review
- Review notes from 20160517_US_Realm_SC_Call
- Action Items
- Review Items
- Review Allergy and Intolerance Substance Value Set(s)Definition Informative Document
- Review QRDA Category I STU
- Review QRDA Category III STU
- Review Newborn Screening Lab Results IG
- Review HL7 CDA Implementation Guide for Inpatient and Ambulatory Healthcare Provider Reporting to Birth Defect Registries
Discussion:
- Review of any outstanding issues
Minutes
Meeting Outcomes
Actions
|
Next Meeting/Preliminary Agenda Items
|
© 2016 Health Level Seven® International. All rights reserved